<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neural Plast</journal-id>
<journal-id journal-id-type="iso-abbrev">Neural Plast</journal-id>
<journal-id journal-id-type="publisher-id">NP</journal-id>
<journal-title-group>
<journal-title>Neural Plasticity</journal-title>
</journal-title-group>
<issn pub-type="ppub">2090-5904</issn>
<issn pub-type="epub">1687-5443</issn>
<publisher>
<publisher-name>Hindawi</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30402088</article-id>
<article-id pub-id-type="pmc">6192167</article-id>
<article-id pub-id-type="doi">10.1155/2018/8423420</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impaired GABA Neural Circuits Are Critical for Fragile X Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Gao</surname>
<given-names>Fei</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Lijun</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Zhongzhen</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Tao</given-names>
</name>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-4904-5459</contrib-id>
<name>
<surname>Xu</surname>
<given-names>Hui</given-names>
</name>
<email>xubz@fmmu.edu.cn</email>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2860-7851</contrib-id>
<name>
<surname>Zhao</surname>
<given-names>Huan</given-names>
</name>
<email>zhaohuanjiyi1@163.com</email>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>Department of Anesthesiology, Heze Municipal Hospital, Heze, 274031 Shandong, China</aff>
<aff id="I2">
<sup>2</sup>Department of Pain Treatment, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China</aff>
<aff id="I3">
<sup>3</sup>Department of Neurobiology and Collaborative Innovation Center for Brain Science, School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China</aff>
<author-notes>
<fn fn-type="other">
<p>Guest Editor: Jolanta Dorszewska</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>3</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>2018</volume>
<elocation-id>8423420</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>6</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>9</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Fei Gao et al.</copyright-statement>
<copyright-year>2018</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Fragile X syndrome (FXS) is an inheritable neuropsychological disease caused by silence of the <italic>fmr1</italic> gene and the deficiency of Fragile X mental retardation protein (FMRP). Patients present neuronal alterations that lead to severe intellectual disability and altered sleep rhythms. However, the neural circuit mechanisms underlying FXS remain unclear. Previous studies have suggested that metabolic glutamate and gamma-aminobutyric acid (GABA) receptors/circuits are two counter-balanced factors involved in FXS pathophysiology. More and more studies demonstrated that attenuated GABAergic circuits in the absence of FMRP are critical for abnormal progression of FXS. Here, we reviewed the changes of GABA neural circuits that were attributed to intellectual-deficient FXS, from several aspects including deregulated GABA metabolism, decreased expressions of GABA receptor subunits, and impaired GABAergic neural circuits. Furthermore, the activities of GABA neural circuits are modulated by circadian rhythm of FMRP metabolism and reviewed the abnormal condition of FXS mice or patients.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>National Natural Science Foundation of China</funding-source>
<award-id>81671081</award-id>
<award-id>31371120</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Introduction</title>
<p>Fragile X mental retardation protein (FMRP) is widely expressed in neurons and glia in the brain and acts as an “interactor” regulating ribosome stalling, translational control, and synaptic plasticity in brain circuits [<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B3">3</xref>]. FMRP contributes to cognition, emotions, and memory through the referred “interactor” role as well. Fragile X syndrome (FXS) patients are deficient of FMRP due to <italic>fmr1</italic> gene silence caused by a CGG trinucleotide amplification on Xq27.3 in the 5′-UTR on chromosome [<xref ref-type="bibr" rid="B4">4</xref>]. According to CGG trinucleotide expansion and clinical symptoms, FM allele mutation-related syndromes could be divided into FXS (&gt;200 repeats) and FXTAS (55–199 repeats) during early diagnosis of FXS. For example, methylation-specific quantitative melt analysis (MS-QMA), respectively, identified methylation mosaicism in an additional 15% and 11% of patients in the Chilean and Australian reports, suggesting the presence of a cryptic FM [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>]. Other methods include a variety of polymerase chain reaction (PCR) techniques, such as high polymorphism markers for preimplantation genetic diagnosis (PGD) of FXS [<xref ref-type="bibr" rid="B7">7</xref>] and two PCR analyses (PCR screening and PCR premutation) [<xref ref-type="bibr" rid="B8">8</xref>]. However, it is difficult to draw a solid criterion due to different inclusive criteria, diagnostic methods, and sample sizes within each study. Although frequencies of clinical characteristics were different between ethnicities, especially in Asian and African people, which provided evidence for genetic counseling [<xref ref-type="bibr" rid="B9">9</xref>], FXS is still difficult to be diagnosed on the account of a lack of an obvious phenotype at birth and during prepuberty in clinic.</p>
<p>Previous studies have illustrated that FXS is caused by the alteration at multiple levels from mRNA shuttling to synaptic plasticity and behavioral phenotypes [<xref ref-type="bibr" rid="B10">10</xref>]. For example, FMRP regulated proteins in the modulation of synaptic plasticity, which maintain spine shape and dynamics [<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B13">13</xref>]. The retardation of FMRP leads to abnormal group I metabotropic glutamate receptor (mGluR) signaling, together with the loss of AMPA and NMDA receptors [<xref ref-type="bibr" rid="B2">2</xref>], although recently clinical trials targeting on mGluR1 failed in FXR patients [<xref ref-type="bibr" rid="B14">14</xref>]. Specifically, the enzymes for GABA synthesis and degradation, GABA membrane transporters, and a GABA receptor scaffolding protein are downregulated in the absence of FMRP [<xref ref-type="bibr" rid="B15">15</xref>]. Besides, FMRP absence GABA<sub>A</sub> receptor <italic>α</italic>1 and <italic>δ</italic> subunits were downregulated in <italic>fmr1</italic> gene knockout mouse and <italic>Drosophila</italic> [<xref ref-type="bibr" rid="B15">15</xref>–<xref ref-type="bibr" rid="B17">17</xref>]. All these studies suggest a perplexing, yet not well understood, link between GABAergic signaling, abnormal neuronal circuits, and dysfunctional behaviors in both FXS animal models and patients. Among all alterations of phenomenal function deficits, dendritic abnormalities are the most evident structural changes in FXS. FMRP regulates neuronal branching as well as dendritic spine morphology and density [<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>]. However, it remains unclear whether plastic changes of inhibitory circuits may cause abnormal spine morphology in FXS or vice versa. In this review, we summarized mechanisms on the effects of inhibitory synapse alteration from circuits to molecular interaction.</p>
</sec>
<sec id="sec2">
<title>2. Altered GABA Metabolisms in FXS Animal Models and Patients</title>
<p>There have been great progresses in the altered GABA metabolism underlying FXTAS/FXS pathogenesis. Mitochondria provides energy for the cell and the brain using most of the energy among all organs. There is mounting evidence that mitochondrial dysregulation systemically contributes to the decreased cell function, even during the neonatal period of mice, first reported by Rizzo et al. [<xref ref-type="bibr" rid="B20">20</xref>]. It is reported that premutated hippocampal neurites contained significantly fewer mitochondria and reduced mitochondria mobility at early stage of differentiation, despite the presence of appreciable FMRP expression [<xref ref-type="bibr" rid="B21">21</xref>]. Together, similar significant deficits of mitochondrial dysfunction, induced by Zn levels, were observed in the Zn-rich regions (the hippocampus and cerebellum of premutation carriers), with some of these effects lasting into adulthood [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Particularly, in dysregulated GABAergic circuits, mitochondrial dysfunction plays vital role from the aspects of mitochondrial structure, number, membrane permeability, transport, fusion, and fission [<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B24">24</xref>–<xref ref-type="bibr" rid="B27">27</xref>]. It is noteworthy that abnormality of mitochondrial structure and function is regulated aberrant expression of microRNAs (miRNA) [<xref ref-type="bibr" rid="B28">28</xref>], while few report functions of miRNAs on GABA metabolism in Fragile X syndrome. More work should be needed to illustrate the perplexing role of deregulated miRNA expression profiles within uncommon GABA neural circuits. In a word, abnormalities of mitochondrial dysfunction induced by FMRP deficits altered GABA metabolism, contributing to the etiology of FXS/FXTAS.</p>
<p>In addition, glutamic acid decarboxylase (GAD) or vesicular GABA transporter protein (VGTA) and vesicular glutamate transporter protein (VGLUT) consist of two components of synaptic balance. Increased expression of VGAT relative to VGLUT expression was shown within the medial nucleus of the trapezoid body (MNTB) in FXS [<xref ref-type="bibr" rid="B29">29</xref>]. Their mechanisms are necessary to be further explored. In FXS patients, a reduced release of GABA from the GABAergic terminals to the presynaptic GABA<sub>B</sub> receptors might induce a decreased inhibition of neurotransmitter spillover, which conversely activated mGluR signaling [<xref ref-type="bibr" rid="B30">30</xref>]. One mechanism of modulating GABA release involves the synthesis and mobilization of endocannabinoids. Activation of GroupImGluRs enables mobilization of endocannabinoids in the postsynaptic neuron and negatively modulates GABA release through a mechanism known as depolarization-induced suppression of inhibition (DSI) [<xref ref-type="bibr" rid="B31">31</xref>]. Therefore, in consideration of endocannabinoid mobilization in the FXS, it is reported that alterations in eCB signaling could contribute to the cognitive dysfunction associated with FXS [<xref ref-type="bibr" rid="B32">32</xref>]. But it only demonstrated DHPG-induced eCB-iLTD, without affecting DSI, at low concentrations. Together, relatively high concentrations of cannabinoids could affect neuropsychiatric disorders via inhibition of monoamine oxidase activity [<xref ref-type="bibr" rid="B33">33</xref>]. Therefore, the loss of FMRP may selectively affect specific inhibitory circuits and more evidence is needed in exploring. In the developing and mature brain, it is critical for cortical balance of excitatory and inhibitory neurons to be properly synchronized at behaviorally relevant frequencies. And thus, alteration of mGluR signaling and GABA metabolisms in this specific type of interneuron is likely to have wide-reaching effects in developing and mature cortical networks.</p>
</sec>
<sec id="sec3">
<title>3. Decreased Expression of GABA Receptor Subunits in FXS Models</title>
<p>The anomalous functions of mGluR-dependent synaptic plasticity have been observed in the hippocampus of <italic>fmr1</italic>-KO mice. Activity-dependent synthesis of FMRP in maintaining forms of synaptic plasticity may be induced by augmented mGluR-LTD in hippocampal neurons [<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B35">35</xref>], while the initiation of long-term potentiation (LTP) is a qualitatively different functional consequence of mGluR1-stimulated protein synthesis at the synapses of the hippocampus where LTD can be induced. Besides, the mGluR theory proposes that stimulation of mGluR1 induces local mRNA translation, resulting in protein synthesis that subsequently enhances the internalization of AMPA receptors [<xref ref-type="bibr" rid="B36">36</xref>]. This model predicts that in the absence of FMRP, the increased translation of a subset of mRNAs disturbs receptor internalization dynamics and then exaggerates internalization of AMPA receptors and weakens the synapse. Interestingly, GABA<sub>B1</sub> and GIRK<sub>2</sub> internalization also is reported to cause rapid and persistent weakening of GABA<sub>B</sub>-activated GIRK-mediated (GABA<sub>B</sub>-GIRK) currents in FXS [<xref ref-type="bibr" rid="B37">37</xref>]. Clearly, the fate of internalized GABA<sub>A</sub>Rs will therefore play a critical role in controlling cell surface receptor levels and hence the efficacy of synaptic inhibition. This may suggest that GABA receptors take internalization process, but its underlying complicated mechanisms still need to be explored. Furthermore, FMRP absence increased steady state surface levels of GABA<sub>A</sub>Rs, showing a dramatic functional effect of increased surface receptor number. The mechanism underlying postendocytic GABA<sub>A</sub>R sorting remains to be demonstrated, and FMRP's particular role in this process is also an area of active research. The impact of FMRP regulation of GABA<sub>A</sub>Rs was recently shown in the hypothalamus, causing decreased food intake and loss of body weight [<xref ref-type="bibr" rid="B38">38</xref>]. An unresolved issue is whether FMRP acts to promote recycling of GABA<sub>A</sub>Rs or prevents their lysosomal degradation.</p>
<p>Furthermore, different subunit combination leads to diverse expression patterns of GABA<sub>A</sub>Rs at specific cell surface. Most surface receptor clusters of <italic>γ</italic>2 receptor subunits are synaptic, while GABA<sub>A</sub>Rs containing <italic>α</italic>5 or <italic>β</italic>3 subunit express higher at extrasynaptic. <italic>δ</italic> subunit is exclusively located outside the synapse at perisynaptic and extrasynaptic locations [<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>]. For example, it is investigated that tonic GABA<sub>A</sub> currents in the subiculum were downregulated in the <italic>fmr1</italic> knockout mouse relative to wild-type animals [<xref ref-type="bibr" rid="B41">41</xref>]. These results were associated with reductions in tonic GABA<sub>A</sub> receptor subunits. Furthermore, more specific results based on the different GABAR subunits need to be expanded to better identify each function in FXS.</p>
<p>Results from all above pave the way for many interesting avenues of research. First, more work is needed to illustrate the molecular causes of impaired inhibition in FXS. In the <italic>Drosophila</italic> model, limited research available has demonstrated that a GABA<sub>A</sub> receptor reduction can lead to behavioral impairments. However, other research from FXS models indicated that the mechanism was likely more complicated and possibly indirect due to not only variable GABA metabolisms but also regional specificity [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B42">42</xref>, <xref ref-type="bibr" rid="B43">43</xref>]. For example, vision process is modulated by different GABA receptors in spread brain via tonic inhibition, such as temporal cortex, lateral geniculate nucleus (LGN) of the thalamus, and vision cortex [<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>], while tonic inhibition is mediated via extrasynaptic <italic>α</italic>5- and <italic>δ</italic>-containing GABA<sub>A</sub>Rs [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B44">44</xref>]. Future research will examine that specific subunits of GABA receptor encode these vision information computations. And it is also worth noting that the role of GABA in the developing CNS is dynamic and variable between brain regions [<xref ref-type="bibr" rid="B40">40</xref>, <xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B46">46</xref>]. Another triggering idea is that impaired inhibition comes from activity-dependent synaptic plasticity alteration during developmentally critical periods [<xref ref-type="bibr" rid="B43">43</xref>, <xref ref-type="bibr" rid="B47">47</xref>]. Both mouse and <italic>Drosophila</italic> FXS models show impaired critical period plasticity, and early activity is critical for shaping E/I synaptic balance [<xref ref-type="bibr" rid="B48">48</xref>–<xref ref-type="bibr" rid="B50">50</xref>]. These findings indicate that many mechanisms are to be explored among GABAergic neurons, GABA metabolism, and GABA receptor alteration in FXS.</p>
</sec>
<sec id="sec4">
<title>4. Impaired GABAergic Neural Circuits in FXS</title>
<p>Dysfunctional mGluR1/5 signaling in excitatory synaptic circuitry has been considered as one classic mechanism underlying FXS [<xref ref-type="bibr" rid="B51">51</xref>–<xref ref-type="bibr" rid="B53">53</xref>]. But a main characteristic of the impairment is usually attributed to a failure in the inhibition of the central set or the need for a supervisory system to be involved in the inhibition of predominant manners. The increased excitability of hippocampal and neocortical circuits in FXS, due to dysregulation of glutaminergic neurons, can in turn disrupt the normal actions of inhibitory GABAergic neurons [<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B54">54</xref>]. It has long been known that FXS models also display reduced function in inhibitory GABAergic circuits [<xref ref-type="bibr" rid="B55">55</xref>–<xref ref-type="bibr" rid="B57">57</xref>]. Specifically, downregulation of GABA<sub>A</sub> receptor subunits influences both the mRNA and protein levels, which would further increase the excitability of limbic and cortical circuits [<xref ref-type="bibr" rid="B39">39</xref>].</p>
<p>FMRP is widely expressed in GABAergic neurons [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>], and it is also involved in normal interneuron maturation and function modulation [<xref ref-type="bibr" rid="B30">30</xref>, <xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B58">58</xref>]. Recently, it was shown that there were lower expressions of several genes involved in GABA metabolism, including <italic>gad1</italic>, <italic>gat1</italic>, and <italic>gat4</italic>, in the brain of both mouse and <italic>Drosophila</italic> FXS models [<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B60">60</xref>]. It is well known that GABAergic neurons can modulate neurotransmitter release in autocrine or paracrine pattern, via presynaptic GABA<sub>A</sub> and GABA<sub>B</sub> receptors [<xref ref-type="bibr" rid="B61">61</xref>–<xref ref-type="bibr" rid="B63">63</xref>]. It is indicated that dysfunctional GABAergic neurons affect balance of inhibitory/excitatory circuits particularly during early developmental critical periods, via the role of GABA attenuated regulator in FXS models [<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B64">64</xref>].</p>
<p>For now, GABAergic impairments have been reported in FXS models of <italic>Drosophila</italic>, <italic>zebrafish</italic>, and mouse. And GABAergic signaling is essential for regulating neuronal migration, maturation, and circuit formation. Therefore, defects in the GABAergic system are likely to have profound effects on neuron development and circuit work in FXS. Currently, a better understanding of early developmental changes in GABAergic system in FXS would be reckoned as the key insight into the underpinning of the FXS brain. Also, the relationship between GABAergic systems and mGluRs ones, as well as their overlapping plasticity alteration, is taken as the pivotal basement to strengthen a more comprehensive cognition of FXS.</p>
<p>Besides the deficits in learning and memory in these models, one consistent behavioral abnormality they share is altered circadian rhythm behaviors, which potentially mimics the sleep abnormalities seen in patients with fragile X syndrome. Circadian rhythm describes the approximately 24-hour cycles generated by a master pacemaker located in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus of the mammalians and in the ventral lateral neurons (LNvs) of <italic>Drosophila</italic> [<xref ref-type="bibr" rid="B65">65</xref>]. Also, the connections between the SCN and other parts of the system are important for the control of circadian rhythms in the central nervous system [<xref ref-type="bibr" rid="B66">66</xref>]. Interestingly, it has been shown that the loss of FMRP and FXR2P results in arrhythmicity resulting from inappropriate neuronal communication within the central nervous system [<xref ref-type="bibr" rid="B67">67</xref>]. Additionally, the altered expression of the clock component has been observed in FXS animal models [<xref ref-type="bibr" rid="B67">67</xref>, <xref ref-type="bibr" rid="B68">68</xref>]. The upregulation of FMRP increases PER1- and PER2-induced BMAL1–NPAS2 transcriptional activity, suggesting that FMRP is required for regulation of circadian behaviors. Thus, <italic>Drosophila</italic> lacking the <italic>fmr1</italic> gene exhibits altered circadian rhythms. Taken together, these results indicate that fragile X-related proteins might be associated with the induction of abnormal sleep patterns in FXS due to alterations in circadian genes; they may also play a critical role in the regulation of circadian output pathways.</p>
<p>Clinical studies have illustrated that melatonin-dependent signaling pathways can impair vigilance, learning, and memory abilities and may be linked to autistic behaviors such as abnormal anxiety responses [<xref ref-type="bibr" rid="B69">69</xref>, <xref ref-type="bibr" rid="B70">70</xref>]. Low melatonin levels are related with altered GABAergic system [<xref ref-type="bibr" rid="B71">71</xref>]. Furthermore, alterations in the circadian clock mechanism due to abnormal melatonin synthesis can affect the function of GABA neural circuits [<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B72">72</xref>]. Recently, studies using animal models of autism have indicated that clock and clock-related genes may interact in the ASD phenotype and studies using <italic>fmr1</italic> KO mice have implicated clock proteins in sleep alterations in FXS [<xref ref-type="bibr" rid="B73">73</xref>]. Under dysfunctional FMRP conditions, GABA activity is altered by disruptions in intracellular signaling. Recent studies have proposed the existence of abnormalities in melatonin secretion and circadian patterns in individuals with FXS with ASD that are likely to be due to excessive signaling via GABA [<xref ref-type="bibr" rid="B74">74</xref>]. Furthermore, melatonin is helpful for treating the physical alterations of axons and dendritic spines [<xref ref-type="bibr" rid="B75">75</xref>, <xref ref-type="bibr" rid="B76">76</xref>]. In addition, other endocrine hormones, such as oxytocin and insulin, participate GABA neuronal function via abnormal biorhythmic patterns. It is reported that oxytocin-mediated GABA excitatory-inhibitory shift during delivery is abolished in FXS model. During delivery and subsequently hippocampal neurons have elevated intracellular chloride levels and elevated gamma oscillations, which suggests the importance of oxytocin-mediated GABAergic inhibition during the process [<xref ref-type="bibr" rid="B77">77</xref>]. Similarly, the insulin-producing cells (IPCs) are crucial for normal insulin release and insulin-signaling in the brain and are sufficient to restore normal circadian behavior in the <italic>Drosophila</italic> FXS model [<xref ref-type="bibr" rid="B78">78</xref>]. Moreover, IPCs have been demonstrated to receive inputs from multiple neurotransmitters and hormones, including tachykinin, leptin, GABA, and serotonin [<xref ref-type="bibr" rid="B79">79</xref>]. But the specific mechanisms deserve further investigation. In brief summary, alteration of GABA inhibition is not simply linked to amplified mGluR signaling, whereas they both are regulated by circadian clock and circadian genes in depth.</p>
<p>Overall, current issues provide much needed <italic>in vivo</italic> evidence for GABAergic circuit impairments in FXS and set the foundation for future work linking molecular to circuit level to behavioral changes. Addressing altered GABAergic circuit function should lead to more effective treatments for FXS patients.</p>
</sec>
<sec id="sec5">
<title>5. Conclusions</title>
<p>In summary, deregulated GABA metabolism, decreased expressions of GABA receptor subunits, and impaired GABAergic neural circuits contribute to abnormal behaviors in FXS. Importantly, it is noteworthy to be studied that circadian clock genes regulate substantial life activities of organism and are related to the process of growth and development in FXS models and patients. Specifically, GABA inhibition is modulated via dysfunctional biorhythmic patterns of endocrine hormones and <italic>fmr1</italic> gene. And better understanding of the GABA neural circuits will support novel therapeutic methods in FXS.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was supported by the National Natural Science Foundation of China (81671081 and 31371120 to Dr. HX).</p>
</ack>
<sec>
<title>Conflicts of Interest</title>
<p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter</surname>
<given-names>J. D.</given-names>
</name>
<name>
<surname>Bassell</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Dysregulation and restoration of translational homeostasis in fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Nature Reviews Neuroscience</italic>
<year>2015</year>
<volume>16</volume>
<issue>10</issue>
<fpage>595</fpage>
<lpage>605</lpage>
<pub-id pub-id-type="doi">10.1038/nrn4001</pub-id>
<pub-id pub-id-type="other">2-s2.0-84941874736</pub-id>
<pub-id pub-id-type="pmid">26350240</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. J.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Elevated progranulin contributes to synaptic and learning deficit due to loss of fragile X mental retardation protein</article-title>
<source/>
<italic toggle="yes">Brain</italic>
<year>2017</year>
<volume>140</volume>
<issue>12</issue>
<fpage>3215</fpage>
<lpage>3232</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awx265</pub-id>
<pub-id pub-id-type="other">2-s2.0-85038251531</pub-id>
<pub-id pub-id-type="pmid">29096020</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Fragile X mental retardation protein regulates translation by binding directly to the ribosome</article-title>
<source/>
<italic toggle="yes">Molecular Cell</italic>
<year>2014</year>
<volume>54</volume>
<issue>3</issue>
<fpage>407</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1016/j.molcel.2014.03.023</pub-id>
<pub-id pub-id-type="other">2-s2.0-84899839442</pub-id>
<pub-id pub-id-type="pmid">24746697</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todd</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Krans</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome</article-title>
<source/>
<italic toggle="yes">Neuron</italic>
<year>2013</year>
<volume>78</volume>
<issue>3</issue>
<fpage>440</fpage>
<lpage>455</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2013.03.026</pub-id>
<pub-id pub-id-type="other">2-s2.0-84877331220</pub-id>
<pub-id pub-id-type="pmid">23602499</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hwang</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Aliaga</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Arpone</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Partially methylated alleles, microdeletion, and tissue mosaicism in a fragile X male with tremor and ataxia at 30 years of age: a case report</article-title>
<source/>
<italic toggle="yes">American Journal of Medical Genetics Part A</italic>
<year>2016</year>
<volume>170</volume>
<issue>12</issue>
<fpage>3327</fpage>
<lpage>3332</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37954</pub-id>
<pub-id pub-id-type="other">2-s2.0-84989303076</pub-id>
<pub-id pub-id-type="pmid">27696642</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aliaga</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Slater</surname>
<given-names>H. R.</given-names>
</name>
<name>
<surname>Francis</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of males with cryptic Fragile X alleles by methylation-specific quantitative melt analysis</article-title>
<source/>
<italic toggle="yes">Clinical Chemistry</italic>
<year>2016</year>
<volume>62</volume>
<issue>2</issue>
<fpage>343</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2015.244681</pub-id>
<pub-id pub-id-type="other">2-s2.0-84957053503</pub-id>
<pub-id pub-id-type="pmid">26715660</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C. G.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>S. S.</given-names>
</name>
</person-group>
<article-title>Identification of microsatellite markers &lt;1 Mb from the <italic>FMR</italic>1 CGG repeat and development of a single-tube tetradecaplex PCR panel of highly polymorphic markers for preimplantation genetic diagnosis of fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Genetics in Medicine</italic>
<year>2016</year>
<volume>18</volume>
<issue>9</issue>
<fpage>869</fpage>
<lpage>875</lpage>
<pub-id pub-id-type="doi">10.1038/gim.2015.185</pub-id>
<pub-id pub-id-type="other">2-s2.0-84984977872</pub-id>
<pub-id pub-id-type="pmid">26741412</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amancio</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>de O Melo</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>de M Vieira</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Molecular analysis of patients suspected of Fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Genetics and Molecular Research</italic>
<year>2015</year>
<volume>14</volume>
<issue>4</issue>
<fpage>14660</fpage>
<lpage>14669</lpage>
<pub-id pub-id-type="doi">10.4238/2015.November.18.30</pub-id>
<pub-id pub-id-type="other">2-s2.0-84947583734</pub-id>
<pub-id pub-id-type="pmid">26600526</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Charalsawadi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wirojanan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jaruratanasirikul</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruangdaraganon</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Geater</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Limprasert</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Common clinical characteristics and rare medical problems of Fragile X syndrome in Thai patients and review of the literature</article-title>
<source/>
<italic toggle="yes">International Journal of Pediatrics</italic>
<year>2017</year>
<volume>2017</volume>
<fpage>11</fpage>
<pub-id pub-id-type="publisher-id">9318346</pub-id>
<pub-id pub-id-type="doi">10.1155/2017/9318346</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic plasticity, a prominent contributor to the anxiety in Fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Neural Plasticity</italic>
<year>2016</year>
<volume>2016</volume>
<fpage>12</fpage>
<pub-id pub-id-type="publisher-id">9353929</pub-id>
<pub-id pub-id-type="doi">10.1155/2016/9353929</pub-id>
<pub-id pub-id-type="other">2-s2.0-84973392447</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmit</surname>
<given-names>T. L.</given-names>
</name>
<name>
<surname>Dowell</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Maes</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Wilhelm</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>c-Jun N-terminal kinase regulates mGluR-dependent expression of post-synaptic FMRP target proteins</article-title>
<source/>
<italic toggle="yes">Journal of Neurochemistry</italic>
<year>2013</year>
<volume>127</volume>
<issue>6</issue>
<fpage>772</fpage>
<lpage>781</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.12453</pub-id>
<pub-id pub-id-type="other">2-s2.0-84890122852</pub-id>
<pub-id pub-id-type="pmid">24047560</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niere</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wilkerson</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>K. M.</given-names>
</name>
</person-group>
<article-title>Evidence for a fragile X mental retardation protein-mediated translational switch in metabotropic glutamate receptor-triggered arc translation and long-term depression</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2012</year>
<volume>32</volume>
<issue>17</issue>
<fpage>5924</fpage>
<lpage>5936</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4650-11.2012</pub-id>
<pub-id pub-id-type="other">2-s2.0-84860112662</pub-id>
<pub-id pub-id-type="pmid">22539853</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinberg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Webber</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The roles of FMRP-regulated genes in autism spectrum disorder: single- and multiple-hit genetic etiologies</article-title>
<source/>
<italic toggle="yes">American Journal of Human Genetics</italic>
<year>2013</year>
<volume>93</volume>
<issue>5</issue>
<fpage>825</fpage>
<lpage>839</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.09.013</pub-id>
<pub-id pub-id-type="other">2-s2.0-84890227659</pub-id>
<pub-id pub-id-type="pmid">24207117</pub-id>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullard</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Fragile X disappointments upset autism ambitions</article-title>
<source/>
<italic toggle="yes">Nature Reviews Drug Discovery</italic>
<year>2015</year>
<volume>14</volume>
<issue>3</issue>
<fpage>151</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1038/nrd4555</pub-id>
<pub-id pub-id-type="other">2-s2.0-84924047062</pub-id>
<pub-id pub-id-type="pmid">25722228</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gatto</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Pereira</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Broadie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>GABAergic circuit dysfunction in the <italic>Drosophila</italic> Fragile X syndrome model</article-title>
<source/>
<italic toggle="yes">Neurobiology of Disease</italic>
<year>2014</year>
<volume>65</volume>
<fpage>142</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2014.01.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893554389</pub-id>
<pub-id pub-id-type="pmid">24423648</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabanov</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Braat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D'Andrea</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impaired GABAergic inhibition in the hippocampus of <italic>Fmr1</italic> knockout mice</article-title>
<source/>
<italic toggle="yes">Neuropharmacology</italic>
<year>2017</year>
<volume>116</volume>
<fpage>71</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2016.12.010</pub-id>
<pub-id pub-id-type="other">2-s2.0-85008158279</pub-id>
<pub-id pub-id-type="pmid">28012946</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>D'Hulst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heulens</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The GABAA receptor is an FMRP target with therapeutic potential in fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Cell Cycle</italic>
<year>2015</year>
<volume>14</volume>
<issue>18</issue>
<fpage>2985</fpage>
<lpage>2995</lpage>
<pub-id pub-id-type="doi">10.4161/15384101.2014.989114</pub-id>
<pub-id pub-id-type="other">2-s2.0-84942021759</pub-id>
<pub-id pub-id-type="pmid">25790165</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scotto-Lomassese</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nissant</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mota</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fragile X mental retardation protein regulates new neuron differentiation in the adult olfactory bulb</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2011</year>
<volume>31</volume>
<issue>6</issue>
<fpage>2205</fpage>
<lpage>2215</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5514-10.2011</pub-id>
<pub-id pub-id-type="other">2-s2.0-79951535135</pub-id>
<pub-id pub-id-type="pmid">21307257</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khayachi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gwizdek</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Poupon</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sumoylation regulates FMRP-mediated dendritic spine elimination and maturation</article-title>
<source/>
<italic toggle="yes">Nature Communications</italic>
<year>2018</year>
<volume>9</volume>
<issue>1</issue>
<fpage>p. 757</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-03222-y</pub-id>
<pub-id pub-id-type="other">2-s2.0-85042526333</pub-id>
<pub-id pub-id-type="pmid">29472612</pub-id>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rizzo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pizza</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Scaglione</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A case of fragile X premutation tremor/ataxia syndrome with evidence of mitochondrial dysfunction</article-title>
<source/>
<italic toggle="yes">Movement Disorders</italic>
<year>2006</year>
<volume>21</volume>
<issue>9</issue>
<fpage>1541</fpage>
<lpage>1542</lpage>
<pub-id pub-id-type="doi">10.1002/mds.21037</pub-id>
<pub-id pub-id-type="other">2-s2.0-33750346920</pub-id>
<pub-id pub-id-type="pmid">16830323</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hulsizer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhanced asynchronous Ca<sup>2+</sup> oscillations associated with impaired glutamate transport in cortical astrocytes expressing <italic>Fmr1</italic> gene premutation expansion</article-title>
<source/>
<italic toggle="yes">Journal of Biological Chemistry</italic>
<year>2013</year>
<volume>288</volume>
<issue>19</issue>
<fpage>13831</fpage>
<lpage>13841</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M112.441055</pub-id>
<pub-id pub-id-type="other">2-s2.0-84877705387</pub-id>
<pub-id pub-id-type="pmid">23553633</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napoli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ross-Inta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered zinc transport disrupts mitochondrial protein processing/import in fragile X-associated tremor/ataxia syndrome</article-title>
<source/>
<italic toggle="yes">Human Molecular Genetics</italic>
<year>2011</year>
<volume>20</volume>
<issue>15</issue>
<fpage>3079</fpage>
<lpage>3092</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr211</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960111223</pub-id>
<pub-id pub-id-type="pmid">21558427</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Napoli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ross-Inta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Premutation in the Fragile X mental retardation 1 (<italic>FMR1</italic>) gene affects maternal Zn-milk and perinatal brain bioenergetics and scaffolding</article-title>
<source/>
<italic toggle="yes">Frontiers in Neuroscience</italic>
<year>2016</year>
<volume>10</volume>
<fpage>p. 159</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2016.00159</pub-id>
<pub-id pub-id-type="other">2-s2.0-84966333832</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagerman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Au</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hagerman</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>FMR1 premutation and full mutation molecular mechanisms related to autism</article-title>
<source/>
<italic toggle="yes">Journal of Neurodevelopmental Disorders</italic>
<year>2011</year>
<volume>3</volume>
<issue>3</issue>
<fpage>211</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1007/s11689-011-9084-5</pub-id>
<pub-id pub-id-type="other">2-s2.0-80955178868</pub-id>
<pub-id pub-id-type="pmid">21617890</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagerman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hoem</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hagerman</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Fragile X and autism: intertwined at the molecular level leading to targeted treatments</article-title>
<source/>
<italic toggle="yes">Molecular Autism</italic>
<year>2010</year>
<volume>1</volume>
<issue>1</issue>
<fpage>p. 12</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-1-12</pub-id>
<pub-id pub-id-type="other">2-s2.0-79953709471</pub-id>
<pub-id pub-id-type="pmid">20858229</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hulsizer</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Early mitochondrial abnormalities in hippocampal neurons cultured from Fmr1 pre-mutation mouse model</article-title>
<source/>
<italic toggle="yes">Journal of Neurochemistry</italic>
<year>2012</year>
<volume>123</volume>
<issue>4</issue>
<fpage>613</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2012.07936.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867576326</pub-id>
<pub-id pub-id-type="pmid">22924671</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>
<italic>Drosophila</italic> FMRP regulates microtubule network formation and axonal transport of mitochondria</article-title>
<source/>
<italic toggle="yes">Human Molecular Genetics</italic>
<year>2011</year>
<volume>20</volume>
<issue>1</issue>
<fpage>51</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddq431</pub-id>
<pub-id pub-id-type="other">2-s2.0-79951533987</pub-id>
<pub-id pub-id-type="pmid">20935173</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Richter-Dennerlein</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dennerlein</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rehling</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Integrating mitochondrial translation into the cellular context</article-title>
<source/>
<italic toggle="yes">Nature Reviews Molecular Cell Biology</italic>
<year>2015</year>
<volume>16</volume>
<issue>10</issue>
<fpage>586</fpage>
<lpage>592</lpage>
<pub-id pub-id-type="doi">10.1038/nrm4051</pub-id>
<pub-id pub-id-type="other">2-s2.0-84951570522</pub-id>
<pub-id pub-id-type="pmid">26535422</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotschafer</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Marshak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cramer</surname>
<given-names>K. S.</given-names>
</name>
</person-group>
<article-title>Deletion of <italic>Fmr1</italic> alters function and synaptic inputs in the auditory brainstem</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2015</year>
<volume>10</volume>
<issue>2, article e0117266</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0117266</pub-id>
<pub-id pub-id-type="other">2-s2.0-84922983607</pub-id>
<pub-id pub-id-type="pmid">25679778</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lange</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Jüngling</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Paulukat</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Glutamic acid decarboxylase 65: a link between GABAergic synaptic plasticity in the lateral amygdala and conditioned fear generalization</article-title>
<source/>
<italic toggle="yes">Neuropsychopharmacology</italic>
<year>2014</year>
<volume>39</volume>
<issue>9</issue>
<fpage>2211</fpage>
<lpage>2220</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2014.72</pub-id>
<pub-id pub-id-type="other">2-s2.0-84904461359</pub-id>
<pub-id pub-id-type="pmid">24663011</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varma</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Carlson</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Ledent</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alger</surname>
<given-names>B. E.</given-names>
</name>
</person-group>
<article-title>Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2001</year>
<volume>21</volume>
<issue>24, article Rc188</issue>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-24-j0003.2001</pub-id>
<pub-id pub-id-type="pmid">11734603</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alger</surname>
<given-names>B. E.</given-names>
</name>
</person-group>
<article-title>Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2010</year>
<volume>30</volume>
<issue>16</issue>
<fpage>5724</fpage>
<lpage>5729</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0795-10.2010</pub-id>
<pub-id pub-id-type="other">2-s2.0-77951528668</pub-id>
<pub-id pub-id-type="pmid">20410124</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisar</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Inhibition of monoamine oxidase activity by cannabinoids</article-title>
<source/>
<italic toggle="yes">Naunyn-Schmiedeberg's Archives of Pharmacology</italic>
<year>2010</year>
<volume>381</volume>
<issue>6</issue>
<fpage>563</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1007/s00210-010-0517-6</pub-id>
<pub-id pub-id-type="other">2-s2.0-77953232046</pub-id>
<pub-id pub-id-type="pmid">20401651</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Klann</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>D. L.</given-names>
</name>
</person-group>
<article-title>Altered hippocampal synaptic plasticity in the <italic>FMR1</italic> gene family knockout mouse models</article-title>
<source/>
<italic toggle="yes">Journal of Neurophysiology</italic>
<year>2009</year>
<volume>101</volume>
<issue>5</issue>
<fpage>2572</fpage>
<lpage>2580</lpage>
<pub-id pub-id-type="doi">10.1152/jn.90558.2008</pub-id>
<pub-id pub-id-type="other">2-s2.0-65649083055</pub-id>
<pub-id pub-id-type="pmid">19244359</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iliff</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Renoux</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Krans</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Usdin</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sutton</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>P. K.</given-names>
</name>
</person-group>
<article-title>Impaired activity-dependent FMRP translation and enhanced mGluR-dependent LTD in Fragile X premutation mice</article-title>
<source/>
<italic toggle="yes">Human Molecular Genetics</italic>
<year>2013</year>
<volume>22</volume>
<issue>6</issue>
<fpage>1180</fpage>
<lpage>1192</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds525</pub-id>
<pub-id pub-id-type="other">2-s2.0-84874535035</pub-id>
<pub-id pub-id-type="pmid">23250915</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Zhuo</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent <italic>α</italic>-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization</article-title>
<source/>
<italic toggle="yes">Journal of Biological Chemistry</italic>
<year>2010</year>
<volume>285</volume>
<issue>28</issue>
<fpage>21888</fpage>
<lpage>21901</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M110.116293</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954368724</pub-id>
<pub-id pub-id-type="pmid">20457613</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecca</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pelosi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tchenio</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rescue of GABA<sub>B</sub> and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice</article-title>
<source/>
<italic toggle="yes">Nature Medicine</italic>
<year>2016</year>
<volume>22</volume>
<issue>3</issue>
<fpage>254</fpage>
<lpage>261</lpage>
<pub-id pub-id-type="doi">10.1038/nm.4037</pub-id>
<pub-id pub-id-type="other">2-s2.0-84955603006</pub-id>
<pub-id pub-id-type="pmid">26808347</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>Q.</given-names>
</name>
</person-group>
<article-title>Regulation of GABAA receptors by fragile X mental retardation protein</article-title>
<source/>
<italic toggle="yes">International Journal of Physiology, Pathophysiology and Pharmacology</italic>
<year>2013</year>
<volume>5</volume>
<issue>3</issue>
<fpage>169</fpage>
<lpage>176</lpage>
<pub-id pub-id-type="pmid">24044036</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drexel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kirchmair</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sperk</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Changes in the expression of GABA<sub>A</sub> receptor subunit mRNAs in parahippocampal areas after kainic acid induced seizures</article-title>
<source/>
<italic toggle="yes">Frontiers in Neural Circuits</italic>
<year>2013</year>
<volume>7</volume>
<fpage>p. 142</fpage>
<pub-id pub-id-type="doi">10.3389/fncir.2013.00142</pub-id>
<pub-id pub-id-type="other">2-s2.0-84885082331</pub-id>
<pub-id pub-id-type="pmid">24065890</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Papouin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seguela</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Avoli</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Downregulation of tonic GABAergic inhibition in a mouse model of fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Cerebral Cortex</italic>
<year>2009</year>
<volume>19</volume>
<issue>7</issue>
<fpage>1515</fpage>
<lpage>1520</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhn159</pub-id>
<pub-id pub-id-type="other">2-s2.0-67649427508</pub-id>
<pub-id pub-id-type="pmid">18787232</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>X.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Decreased surface expression of the <italic>δ</italic> subunit of the GABA<sub>A</sub> receptor contributes to reduced tonic inhibition in dentate granule cells in a mouse model of fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Experimental Neurology</italic>
<year>2017</year>
<volume>297</volume>
<fpage>168</fpage>
<lpage>178</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.08.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-85027893837</pub-id>
<pub-id pub-id-type="pmid">28822839</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Hulst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heulens</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>van der Aa</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Positron emission tomography (PET) quantification of GABA<sub>A</sub> receptors in the brain of Fragile X patients</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2015</year>
<volume>10</volume>
<issue>7, article e0131486</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0131486</pub-id>
<pub-id pub-id-type="other">2-s2.0-84942036668</pub-id>
<pub-id pub-id-type="pmid">26222316</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kratovac</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Corbin</surname>
<given-names>J. G.</given-names>
</name>
</person-group>
<article-title>Developmental changes in expression of inhibitory neuronal proteins in the Fragile X syndrome mouse basolateral amygdala</article-title>
<source/>
<italic toggle="yes">Brain Research</italic>
<year>2013</year>
<volume>1537</volume>
<fpage>69</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2013.08.052</pub-id>
<pub-id pub-id-type="other">2-s2.0-84887242022</pub-id>
<pub-id pub-id-type="pmid">24008143</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frederikse</surname>
<given-names>P. H.</given-names>
</name>
<name>
<surname>Nandanoor</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kasinathan</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Fragile X syndrome FMRP co-localizes with regulatory targets PSD-95, GABA receptors, CaMKII<italic>α</italic>, and mGluR5 at fiber cell membranes in the eye lens</article-title>
<source/>
<italic toggle="yes">Neurochemical Research</italic>
<year>2015</year>
<volume>40</volume>
<issue>11</issue>
<fpage>2167</fpage>
<lpage>2176</lpage>
<pub-id pub-id-type="doi">10.1007/s11064-015-1702-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-84947021201</pub-id>
<pub-id pub-id-type="pmid">26298628</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirsch</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Sommer</surname>
<given-names>F. T.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>L. M.</given-names>
</name>
</person-group>
<article-title>How inhibitory circuits in the thalamus serve vision</article-title>
<source/>
<italic toggle="yes">Annual Review of Neuroscience</italic>
<year>2015</year>
<volume>38</volume>
<issue>1</issue>
<fpage>309</fpage>
<lpage>329</lpage>
<pub-id pub-id-type="doi">10.1146/annurev-neuro-071013-014229</pub-id>
<pub-id pub-id-type="other">2-s2.0-84937397927</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broek</surname>
<given-names>J. A. C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>de Gruiter</surname>
<given-names>H. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synaptic vesicle dynamic changes in a model of fragile X</article-title>
<source/>
<italic toggle="yes">Molecular Autism</italic>
<year>2016</year>
<volume>7</volume>
<issue>1</issue>
<fpage>p. 17</fpage>
<pub-id pub-id-type="doi">10.1186/s13229-016-0080-1</pub-id>
<pub-id pub-id-type="other">2-s2.0-84963781187</pub-id>
<pub-id pub-id-type="pmid">26933487</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doll</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Broadie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Activity-dependent FMRP requirements in development of the neural circuitry of learning and memory</article-title>
<source/>
<italic toggle="yes">Development</italic>
<year>2015</year>
<volume>142</volume>
<issue>7</issue>
<fpage>1346</fpage>
<lpage>1356</lpage>
<pub-id pub-id-type="doi">10.1242/dev.117127</pub-id>
<pub-id pub-id-type="other">2-s2.0-84930690233</pub-id>
<pub-id pub-id-type="pmid">25804740</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doll</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Broadie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Impaired activity-dependent neural circuit assembly and refinement in autism spectrum disorder genetic models</article-title>
<source/>
<italic toggle="yes">Frontiers in Cellular Neuroscience</italic>
<year>2014</year>
<volume>8</volume>
<fpage>p. 30</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2014.00030</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893578436</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Corbin</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Huntsman</surname>
<given-names>M. M.</given-names>
</name>
</person-group>
<article-title>Deficient tonic GABAergic conductance and synaptic balance in the fragile X syndrome amygdala</article-title>
<source/>
<italic toggle="yes">Journal of Neurophysiology</italic>
<year>2014</year>
<volume>112</volume>
<issue>4</issue>
<fpage>890</fpage>
<lpage>902</lpage>
<pub-id pub-id-type="doi">10.1152/jn.00597.2013</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906078573</pub-id>
<pub-id pub-id-type="pmid">24848467</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Westmark</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Hays</surname>
<given-names>S. A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>APP causes hyperexcitability in Fragile X mice</article-title>
<source/>
<italic toggle="yes">Frontiers in Molecular Neuroscience</italic>
<year>2016</year>
<volume>9</volume>
<fpage>p. 147</fpage>
<pub-id pub-id-type="doi">10.3389/fnmol.2016.00147</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>S.-C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C.-C.</given-names>
</name>
<name>
<surname>Orejanera</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Manzoni</surname>
<given-names>O. J.</given-names>
</name>
<name>
<surname>Gean</surname>
<given-names>P.-W.</given-names>
</name>
</person-group>
<article-title>Inhibition of spontaneous recovery of fear by mGluR5 after prolonged extinction training</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2013</year>
<volume>8</volume>
<issue>3, article e59580</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0059580</pub-id>
<pub-id pub-id-type="other">2-s2.0-84875327191</pub-id>
<pub-id pub-id-type="pmid">23555716</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Michalon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bruns</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Risterucci</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice</article-title>
<source/>
<italic toggle="yes">Biological Psychiatry</italic>
<year>2014</year>
<volume>75</volume>
<issue>3</issue>
<fpage>189</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2013.05.038</pub-id>
<pub-id pub-id-type="other">2-s2.0-84891614268</pub-id>
<pub-id pub-id-type="pmid">23910948</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pop</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Gomez-Mancilla</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gasparini</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Fragile X syndrome: a preclinical review on metabotropic glutamate receptor 5 (mGluR5) antagonists and drug development</article-title>
<source/>
<italic toggle="yes">Psychopharmacology</italic>
<year>2014</year>
<volume>231</volume>
<issue>6</issue>
<fpage>1217</fpage>
<lpage>1226</lpage>
<pub-id pub-id-type="doi">10.1007/s00213-013-3330-3</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896739499</pub-id>
<pub-id pub-id-type="pmid">24232444</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straiker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>K. T.</given-names>
</name>
<name>
<surname>Mackie</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>
<italic>Fmr1</italic> deletion enhances and ultimately desensitizes CB<sub>1</sub> signaling in autaptic hippocampal neurons</article-title>
<source/>
<italic toggle="yes">Neurobiology of Disease</italic>
<year>2013</year>
<volume>56</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2013.04.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-84877012162</pub-id>
<pub-id pub-id-type="pmid">23578490</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nomura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Musial</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J. J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Delayed maturation of fast-spiking interneurons is rectified by activation of the TrkB receptor in the mouse model of Fragile X syndrome</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2017</year>
<volume>37</volume>
<issue>47</issue>
<fpage>11298</fpage>
<lpage>11310</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.2893-16.2017</pub-id>
<pub-id pub-id-type="other">2-s2.0-85035106786</pub-id>
<pub-id pub-id-type="pmid">29038238</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruby</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Falvey</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kulesza</surname>
<given-names>R. J.</given-names>
</name>
</person-group>
<article-title>Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats</article-title>
<source/>
<italic toggle="yes">Neuroscience</italic>
<year>2015</year>
<volume>303</volume>
<fpage>285</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.06.061</pub-id>
<pub-id pub-id-type="other">2-s2.0-84937239430</pub-id>
<pub-id pub-id-type="pmid">26166728</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franco</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Okray</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Linneweber</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Yaksi</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Reduced lateral inhibition impairs olfactory computations and behaviors in a <italic>Drosophila</italic> model of fragile X syndrome</article-title>
<source/>
<italic toggle="yes">Current Biology</italic>
<year>2017</year>
<volume>27</volume>
<issue>8</issue>
<fpage>1111</fpage>
<lpage>1123</lpage>
<pub-id pub-id-type="doi">10.1016/j.cub.2017.02.065</pub-id>
<pub-id pub-id-type="other">2-s2.0-85016515739</pub-id>
<pub-id pub-id-type="pmid">28366741</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olmos-Serrano</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Paluszkiewicz</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Corbin</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Huntsman</surname>
<given-names>M. M.</given-names>
</name>
</person-group>
<article-title>Defective GABAergic neurotransmission and pharmacological rescue of neuronal hyperexcitability in the amygdala in a mouse model of fragile X syndrome</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2010</year>
<volume>30</volume>
<issue>29</issue>
<fpage>9929</fpage>
<lpage>9938</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1714-10.2010</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954851827</pub-id>
<pub-id pub-id-type="pmid">20660275</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christie</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Akins</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Schwob</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>J. R.</given-names>
</name>
</person-group>
<article-title>The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits</article-title>
<source/>
<italic toggle="yes">The Journal of Neuroscience</italic>
<year>2009</year>
<volume>29</volume>
<issue>5</issue>
<fpage>1514</fpage>
<lpage>1524</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.3937-08.2009</pub-id>
<pub-id pub-id-type="other">2-s2.0-59649126241</pub-id>
<pub-id pub-id-type="pmid">19193898</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>El Idrissi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Scalia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Trenkner</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>W. T.</given-names>
</name>
<name>
<surname>Dobkin</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Decreased GABA<sub>A</sub> receptor expression in the seizure-prone fragile X mouse</article-title>
<source/>
<italic toggle="yes">Neuroscience Letters</italic>
<year>2005</year>
<volume>377</volume>
<issue>3</issue>
<fpage>141</fpage>
<lpage>146</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2004.11.087</pub-id>
<pub-id pub-id-type="other">2-s2.0-14744291567</pub-id>
<pub-id pub-id-type="pmid">15755515</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trigo</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Marty</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stell</surname>
<given-names>B. M.</given-names>
</name>
</person-group>
<article-title>Axonal GABA<sub>A</sub> receptors</article-title>
<source/>
<italic toggle="yes">The European Journal of Neuroscience</italic>
<year>2008</year>
<volume>28</volume>
<issue>5</issue>
<fpage>841</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06404.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-50449105119</pub-id>
<pub-id pub-id-type="pmid">18691324</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adusei</surname>
<given-names>D. C.</given-names>
</name>
<name>
<surname>Pacey</surname>
<given-names>L. K. K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hampson</surname>
<given-names>D. R.</given-names>
</name>
</person-group>
<article-title>Early developmental alterations in GABAergic protein expression in fragile X knockout mice</article-title>
<source/>
<italic toggle="yes">Neuropharmacology</italic>
<year>2010</year>
<volume>59</volume>
<issue>3</issue>
<fpage>167</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2010.05.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954143021</pub-id>
<pub-id pub-id-type="pmid">20470805</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>D'Hulst</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Heulens</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brouwer</surname>
<given-names>J. R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of the GABAergic system in animal models for fragile X syndrome and fragile X associated tremor/ataxia syndrome (FXTAS)</article-title>
<source/>
<italic toggle="yes">Brain Research</italic>
<year>2009</year>
<volume>1253</volume>
<fpage>176</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainres.2008.11.075</pub-id>
<pub-id pub-id-type="other">2-s2.0-58249135425</pub-id>
<pub-id pub-id-type="pmid">19070606</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Chadchankar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Vien</surname>
<given-names>T. N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deficits in the activity of presynaptic <italic>γ</italic>-aminobutyric acid type B receptors contribute to altered neuronal excitability in fragile X syndrome</article-title>
<source/>
<italic toggle="yes">The Journal of Biological Chemistry</italic>
<year>2017</year>
<volume>292</volume>
<issue>16</issue>
<fpage>6621</fpage>
<lpage>6632</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M116.772541</pub-id>
<pub-id pub-id-type="other">2-s2.0-85018567481</pub-id>
<pub-id pub-id-type="pmid">28213518</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muraro</surname>
<given-names>N. I.</given-names>
</name>
<name>
<surname>Pirez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ceriani</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>The circadian system: plasticity at many levels</article-title>
<source/>
<italic toggle="yes">Neuroscience</italic>
<year>2013</year>
<volume>247</volume>
<fpage>280</fpage>
<lpage>293</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.05.036</pub-id>
<pub-id pub-id-type="other">2-s2.0-84879714654</pub-id>
<pub-id pub-id-type="pmid">23727010</pub-id>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schwartz</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>M. T.</given-names>
</name>
</person-group>
<article-title>The suprachiasmatic nuclei contain a tetrodotoxin-resistant circadian pacemaker</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>1987</year>
<volume>84</volume>
<issue>6</issue>
<fpage>1694</fpage>
<lpage>1698</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.84.6.1694</pub-id>
<pub-id pub-id-type="other">2-s2.0-0343737705</pub-id>
<pub-id pub-id-type="pmid">3470750</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jud</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Fragile X-related proteins regulate mammalian circadian behavioral rhythms</article-title>
<source/>
<italic toggle="yes">American Journal of Human Genetics</italic>
<year>2008</year>
<volume>83</volume>
<issue>1</issue>
<fpage>43</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2008.06.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-46149091254</pub-id>
<pub-id pub-id-type="pmid">18589395</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Poidevin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Circadian rhythm-dependent alterations of gene expression in <italic>Drosophila</italic> brain lacking fragile X mental retardation protein</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2012</year>
<volume>7</volume>
<issue>5, article e37937</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0037937</pub-id>
<pub-id pub-id-type="other">2-s2.0-84861395945</pub-id>
<pub-id pub-id-type="pmid">22655085</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kulman</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lissoni</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rovelli</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Roselli</surname>
<given-names>M. G.</given-names>
</name>
<name>
<surname>Brivio</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sequeri</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Evidence of pineal endocrine hypofunction in autistic children</article-title>
<source/>
<italic toggle="yes">Neuro Endocrinology Letters</italic>
<year>2000</year>
<volume>21</volume>
<issue>1</issue>
<fpage>31</fpage>
<lpage>34</lpage>
<pub-id pub-id-type="pmid">11455326</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Won</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Melatonin as a novel interventional candidate for Fragile X syndrome with autism spectrum disorder in humans</article-title>
<source/>
<italic toggle="yes">International Journal of Molecular Sciences</italic>
<year>2017</year>
<volume>18</volume>
<issue>6</issue>
<pub-id pub-id-type="doi">10.3390/ijms18061314</pub-id>
<pub-id pub-id-type="other">2-s2.0-85021061017</pub-id>
<pub-id pub-id-type="pmid">28632163</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodge</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Carollo</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Lewin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>C. D.</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>D. P.</given-names>
</name>
</person-group>
<article-title>Sleep patterns in children with and without autism spectrum disorders: developmental comparisons</article-title>
<source/>
<italic toggle="yes">Research in Developmental Disabilities</italic>
<year>2014</year>
<volume>35</volume>
<issue>7</issue>
<fpage>1631</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="doi">10.1016/j.ridd.2014.03.037</pub-id>
<pub-id pub-id-type="other">2-s2.0-84899858186</pub-id>
<pub-id pub-id-type="pmid">24780146</pub-id>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassell</surname>
<given-names>G. J.</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>S. T.</given-names>
</name>
</person-group>
<article-title>Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function</article-title>
<source/>
<italic toggle="yes">Neuron</italic>
<year>2008</year>
<volume>60</volume>
<issue>2</issue>
<fpage>201</fpage>
<lpage>214</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.10.004</pub-id>
<pub-id pub-id-type="other">2-s2.0-53849110899</pub-id>
<pub-id pub-id-type="pmid">18957214</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bechara</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Didiot</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Melko</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A novel function for fragile X mental retardation protein in translational activation</article-title>
<source/>
<italic toggle="yes">PLoS Biology</italic>
<year>2009</year>
<volume>7</volume>
<issue>1, article e16</issue>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1000016</pub-id>
<pub-id pub-id-type="other">2-s2.0-58849130167</pub-id>
<pub-id pub-id-type="pmid">19166269</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miranda-Paez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zamudio</surname>
<given-names>S. R.</given-names>
</name>
<name>
<surname>Vazquez-Leon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sandoval-Herrera</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Villanueva-Becerril</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Carli</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Effect of melatonin injection into the periaqueductal gray on antinociception and tonic immobility in male rats</article-title>
<source/>
<italic toggle="yes">Hormones and Behavior</italic>
<year>2017</year>
<volume>89</volume>
<fpage>23</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2016.12.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-85008197490</pub-id>
<pub-id pub-id-type="pmid">27988316</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>R. J.</given-names>
</name>
</person-group>
<article-title>Acute melatonin treatment alters dendritic morphology and circadian clock gene expression in the hippocampus of Siberian hamsters</article-title>
<source/>
<italic toggle="yes">Hippocampus</italic>
<year>2015</year>
<volume>25</volume>
<issue>2</issue>
<fpage>142</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="doi">10.1002/hipo.22358</pub-id>
<pub-id pub-id-type="other">2-s2.0-84921311732</pub-id>
<pub-id pub-id-type="pmid">25160468</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendoza-Viveros</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Ong</surname>
<given-names>J. L. K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>miR-132/212 modulates seasonal adaptation and dendritic morphology of the central circadian clock</article-title>
<source/>
<italic toggle="yes">Cell Reports</italic>
<year>2017</year>
<volume>19</volume>
<issue>3</issue>
<fpage>505</fpage>
<lpage>520</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.057</pub-id>
<pub-id pub-id-type="other">2-s2.0-85017590396</pub-id>
<pub-id pub-id-type="pmid">28423315</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tyzio</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nardou</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>D. C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2014</year>
<volume>343</volume>
<issue>6171</issue>
<fpage>675</fpage>
<lpage>679</lpage>
<pub-id pub-id-type="doi">10.1126/science.1247190</pub-id>
<pub-id pub-id-type="other">2-s2.0-84893640636</pub-id>
<pub-id pub-id-type="pmid">24503856</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monyak</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Emerson</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schoenfeld</surname>
<given-names>B. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Insulin signaling misregulation underlies circadian and cognitive deficits in a <italic>Drosophila</italic> fragile X model</article-title>
<source/>
<italic toggle="yes">Molecular Psychiatry</italic>
<year>2017</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1140</fpage>
<lpage>1148</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2016.51</pub-id>
<pub-id pub-id-type="other">2-s2.0-84964409630</pub-id>
<pub-id pub-id-type="pmid">27090306</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nässel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Kubrak</surname>
<given-names>O. I.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lushchak</surname>
<given-names>O. V.</given-names>
</name>
</person-group>
<article-title>Factors that regulate insulin producing cells and their output in <italic>Drosophila</italic></article-title>
<source/>
<italic toggle="yes">Frontiers in Physiology</italic>
<year>2013</year>
<volume>4</volume>
<fpage>p. 252</fpage>
<pub-id pub-id-type="doi">10.3389/fphys.2013.00252</pub-id>
<pub-id pub-id-type="other">2-s2.0-84884548805</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>